Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension
Author:
Affiliation:
1. Novartis Pharma AG; Basel Switzerland
2. Novartis Horsham Research Centre; Horsham West Sussex UK
3. Novartis Pharmaceuticals; East Hanover USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12584/fullpdf
Reference20 articles.
1. Prognostication in pulmonary arterial hypertension;Agarwal;Heart Fail Clin,2012
2. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension;Hatano;Int Heart J,2010
3. Early detection and management of pulmonary arterial hypertension;Humbert;Eur Respir Rev,2012
4. Imatinib mesylate for the treatment of pulmonary arterial hypertension;Ten;Expert Opin Investig Drugs,2012
5. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension;Park;Catheter Cardiovasc Interv,2008
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective;Critical Reviews in Oncology/Hematology;2024-03
2. Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation;Cancer Chemotherapy and Pharmacology;2023-08-25
3. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session;Current Drug Metabolism;2023-02
4. The Application of Virtual Therapeutic Drug Monitoring to Assess the Pharmacokinetics of Imatinib in a Chinese Cancer Population Group;Journal of Pharmaceutical Sciences;2023-02
5. Therapeutic effects of sildenafil combined with low-dosage imatinib on pulmonary hypertension in five dogs;THAI J VET MED;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3